141875-24-3

Basic information

• Product Name: (2-Fluoro-phenyl)-(1-methyl-1,2,3,4-tetrahydro-quinoxalin-5-yl)-methanone
• Synonyms: (2-Fluoro-phenyl)-(1-methyl-1,2,3,4-tetrahydro-quinoxalin-5-yl)-methanone
• CAS NO: 141875-24-3
• Molecular Weight: 270.306
• Mol File: 141875-24-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2-Fluoro-phenyl)-(1-methyl-1,2,3,4-tetrahydro-quinoxalin-5-yl)-methanone(CAS DataBase Reference)
• NIST Chemistry Reference: (2-Fluoro-phenyl)-(1-methyl-1,2,3,4-tetrahydro-quinoxalin-5-yl)-methanone(141875-24-3)
• EPA Substance Registry System: (2-Fluoro-phenyl)-(1-methyl-1,2,3,4-tetrahydro-quinoxalin-5-yl)-methanone(141875-24-3)

Safety Data

• Hazardous Substances Data: 141875-24-3(Hazardous Substances Data)

Upstream product

• 36438-97-8 1-methyl-1,2,3,4-tetrahydroquinoxaline 
• 394-47-8 2-fluorobenzonitrile 

Downstream Products

• 141875-25-4 2-Bromo-1-[8-(2-fluoro-benzoyl)-4-methyl-3,4-dihydro-2H-quinoxalin-1-yl]-ethanone 
• 141902-49-0 (6S)-1-methyl-5-oxo-6-amino-8-(2-fluorophenyl)-2,3,5,6-tetrahydro-1H-[1,4]diazepino[1,7,6-de]quinoxaline 
• 141902-50-3 (6R)-1-Methyl-5-oxo-6-amino-8-(2-fluorophenyl)-2,3,5,6-tetrahydro-1H-[1,4]diazepino[1,7,6-de]quinoxaline 
• 141875-14-1 9-Amino-7-(2-fluoro-phenyl)-3-methyl-2,3-dihydro-1H,9H-3,8,10a-triaza-cyclohepta[de]naphthalen-10-one 
• 141875-29-8 Methanesulfonic acid 7-(2-fluoro-phenyl)-3-methyl-10-oxo-2,3,9,10-tetrahydro-1H-3,8,10a-triaza-cyclohepta[de]naphthalen-9-yl ester 
• 167645-08-1 Acetic acid 7-(2-fluoro-phenyl)-3-methyl-10-oxo-2,3,9,10-tetrahydro-1H-3,8,10a-triaza-cyclohepta[de]naphthalen-9-yl ester 
• 167645-12-7 7-(2-Fluoro-phenyl)-9-hydroxy-3-methyl-2,3-dihydro-1H,9H-3,8,10a-triaza-cyclohepta[de]naphthalen-10-one 
• 141875-26-5 7-(2-Fluoro-phenyl)-3-methyl-8-oxy-2,3-dihydro-1H,9H-3,8,10a-triaza-cyclohepta[de]naphthalen-10-one 

Relevant articles and documents

Studies on a novel, potent and orally effective cholecystokinin A antagonist, FK-480. Synthesis and structure-activity relationships of FK-480 and related compounds

We prepared various novel tricyclic 1,4-benzodiazepine derivatives as cholecystokinin (CCK) A antagonists, which were evaluated preliminarily for inhibition of 125I-CCK-8 binding to rat pancreatic membranes in vitro and inhibiting effect on CCK